隐形疼痛、可见影响:亟需将女性健康置于风湿与肌肉骨骼疾病优先位置
本文为观点文章,指出风湿与肌肉骨骼疾病(RMDs)在患病率、诊断、治疗和职业风险因素方面存在显著性别差异,女性承受不成比例的负担。女性常经历诊断延迟、初始误诊和治疗可及性不平等,导致结局更差。作者呼吁将RMDs纳入女性健康议程,推动针对性研究、性别敏感诊疗策略和医学教育修订。
要点
- 女性在多种RMDs中患病率和负担更高,且诊断延迟和误诊更常见。
- 职业因素如组织压力和重复性任务使女性更易患RMDs。
- 医学教育、研究和临床实践中的偏见导致女性症状常被忽视或正常化。
核心结论
- RMDs对女性造成不成比例的负担,亟需将其纳入女性健康议程以推动针对性研究和性别敏感诊疗策略。
研究设计与样本
- 本文为观点文章,未报告系统检索范围或样本量。
主要发现
- 骨关节炎、类风湿关节炎、系统性红斑狼疮和纤维肌痛等常见RMDs在女性中患病率更高且负担更重。
- 女性常经历诊断延迟、初始误诊和有效治疗可及性不平等,往往导致更差结局。
- 组织压力和重复性任务等职业因素使女性更易患RMDs。
- 医学教育、研究和临床实践中的偏见导致女性症状常被忽视或正常化。
- RMDs对女性生殖健康、心理健康和社会经济稳定性产生影响。
临床怎么用
- 倡导在欧盟层面将RMDs纳入女性健康议程,推动针对性研究。
- 实施性别敏感的診断和治疗策略,并修订医学教育以减少偏见。
局限性
- 本文为观点文章,未提供原始研究数据或系统评价方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rheumatic and musculoskeletal diseases (RMDs) present a substantial yet often underrecognised public health challenge. This viewpoint article highlights significant sex- and gender-based disparities, where women are disproportionately affected by prevalence, diagnosis, treatment, and occupational risk factors. Many prevalent RMDs, including osteoarthritis, rheumatoid arthritis, systemic lupus erythematosus, and fibromyalgia, exhibit a higher prevalence and greater burden in women. Women frequently experience prolonged diagnostic delays, receive incorrect initial diagnoses, and face unequal access to effective treatments, often leading to worse outcomes. Occupational factors, such as organisational strain and repetitive tasks, also render women more susceptible to RMDs. These inequities are compounded by biases in medical education, research, and clinical practice, where women's symptoms are often dismissed or normalised. The impact extends to reproductive health, mental well-being, and socio-economic stability for women with RMDs. Addressing these pervasive disparities is paramount for achieving health equity and improving overall public health. We advocate for the urgent inclusion of RMDs within the growing Women's Health agenda, particularly at the European Union level, to drive targeted research, implement gender-sensitive diagnostic and treatment strategies, and revise medical education. Collective action is essential to ensure RMDs and their disproportionate impact on women gain the visibility and policy prioritisation they demand.
引用
- Carmona L, Kloppenburg M, Nikiphorou E, et al. Invisible pain, visible impact: the urgent need to prioritise women's health in rheumatic and musculoskeletal diseases. Ann Rheum Dis. 2026. PMID: 42230213. doi:10.1016/j.ard.2026.05.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。